Fei Xiong
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery 40
- Pharmaceutical Science top 2%
- Molecular Medicine top 5%
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 18
- Graphene and Nanomaterials Applications 7
- Characterization and Applications of Magnetic Nanoparticles 7
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 11
- Natural product bioactivities and synthesis 7
- Advanced biosensing and bioanalysis techniques 6
-
- Multiple Myeloma Research and Treatments 7
- Co-authors
- Ning GuFang YangDong LiuHao WangYu ZhangWen‐Cai YeLiang GeShengxin Huang
- Partner nations
- ChinaUnited StatesBangladesh
In The Last Decade
Fei Xiong
105 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Biomaterials 1.1k
- Pharmaceutical Science 225
- Molecular Medicine 133
- Biomedical Engineering 1.0k
- Molecular Biology 988
Countries citing papers authored by Fei Xiong
This map shows the geographic impact of Fei Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Xiong more than expected).
Fields of papers citing papers by Fei Xiong
This network shows the impact of papers produced by Fei Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Xiong. The network helps show where Fei Xiong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fei Xiong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 16 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 16 | |
| 10 | 2021 | 29 | |
| 11 | 2021 | 50 | |
| 12 | 2021 | 3 | |
| 13 | 2019 | 89 | |
| 14 | 2019 | 34 | |
| 15 | 2018 | 28 | |
| 16 | 2018 | 7 | |
| 17 | [2-deoxy-D-glucose modified supermagnetic iron oxide nanoparticles enhance the contrasting effect on MRI of human lung adenocarcinoma A549 tumor in nude mice]. | 2014 | 1 |
| 18 | 2012 | 70 | |
| 19 | 2011 | 21 | |
| 20 | 2010 | 8 |
About Fei Xiong
Fei Xiong is a scholar working on Biomaterials, Pharmaceutical Science and Hematology, having authored 110 papers that have together received 2.9k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (40 papers), Nanoplatforms for cancer theranostics (18 papers), RNA Interference and Gene Delivery (11 papers), Graphene and Nanomaterials Applications (7 papers), Multiple Myeloma Research and Treatments (7 papers), Natural product bioactivities and synthesis (7 papers), Characterization and Applications of Magnetic Nanoparticles (7 papers) and Advanced biosensing and bioanalysis techniques (6 papers). The work is most often cited by research in Biomaterials (1.1k citations), Pharmaceutical Science (225 citations) and Molecular Medicine (133 citations). Fei Xiong has collaborated with scholars based in China, United States and Bangladesh. Frequent co-authors include Ning Gu, Fang Yang, Dong Liu, Hao Wang, Yu Zhang, Wen‐Cai Ye, Liang Ge, Shengxin Huang, Zhu Jia‐bi and Xiaolong Hu. Their work appears in journals such as Advanced Materials, Nano Letters and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.